CiVi Biopharma logo

CiVi Biopharma jobs and careers

Chevy Chase, MD, United States

About CiVi Biopharma

CiVi Biopharma Inc. is a US-based, privately-held biopharmaceutical company, founded in 2016. The Company's research and development activities are focused on creating novel therapies for cardiovascular, metabolic and related diseases. CiVi’s innovative pipeline includes CiVi007, a long-acting PCSK9 third-generation Locked Nucleic Acid antisense molecule being developed for the treatment of hypercholesterolemia and the prevention of cardiovascular disease. In addition, the Company currently has other clinical stage development program activity aimed at treating severe liver diseases.

Founded in 2016 by Henrik Orum and Jess Thiersen.

Founded
2016
Employees
11 to 50
Total funding
$89M
Headquarters
Chevy Chase

Leadership

The top of CiVi Biopharma's org chart, with how many people report into each leader.

CSPhoto of Chuck Shear

Chuck Shear

Chief Development Officer

2 reports

KCPhoto of Kevin Christal

Kevin Christal

COO

1 report

HØPhoto of Henrik Ørum

Henrik Ørum

Chief Scientific Officer

CVPhoto of Christa-Lynn Vampola

Christa-Lynn Vampola

VP, Regulatory and Clinical Science

WBPhoto of Wade Benton

Wade Benton

CDO, Orphan Drugs

JGPhoto of Joel Gervasi

Joel Gervasi

Financial Controller

Board

CF

Christopher Fuglesang

Director

AD

Aaron Davis

Chairman

CN

Carole Nuechterlein

Director

Jobs at CiVi Biopharma

No open positions right now. Explore more companies on TheJobsMap.